Addex' ADX10059 Has Potential For Parkinson's Disease Levodopa Induced Dyskinesia (PD-LID)
Links shared publicly online about this topic.
- 1,749total visits
Addex' ADX10059 Has Potential For Parkinson's Disease Levodopa Induced Dyskinesia (PD-LID)
Allosteric modulation company Addex Pharmaceuticals (SWISS: ADXN) reported that its lead product, ADX10059, which is nearing completion of Phase IIb testing in gastroesophageal reflux disease (GE
View full resource at medicalnewstoday.com
Tags: GERD, Parkinson's Disease, Disease and Condition, Pharma
Most Recently Shared on September 14, 2009 at 2:20 pm By:
Addex' ADX10059 Has Potential For Parkinson's Disease Levodopa Induced Dyskinesia (PD-LID): Allosteric modulatio.. http://bit.ly/ZAL3t
Advertisement
